GigaGen, Inc.

CELL-SEQ

Laboratory devices for detecting genetic sequences;CELL SEQUENCING;Assays and reagents for use in genetic research; Biochemical reagents used for non-medical purposes; Biochemicals for in vitro and in vivo scientific use; Biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research purposes;The wording Cell-Seq has no meaning in a foreign language.;Genetic testing for medical purposes; Genetic testing of animals;Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing;Biochemical research and development; DNA analysis services; Genetic testing for scientific research purposes; Genetic testing of laboratory animals for research purposes; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific research consulting in the field of immunology and oncology; Scientific research in the field of genetics and genetic engineering; Scientific research in the field of immunology and oncology;

CLONOBYTE

Computer software for scientific analysis of genetic sequences; Laboratory devices for detecting genetic sequences;Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Genetic testing for scientific research purposes; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific research consulting in the field of immunology and genetics; Scientific research in the field of genetics and genetic engineering; Scientific research in the field of immunology and genetics;

GIGAGEN

pharmaceutical and therapeutic preparations for the treatment of immune deficiencies, autoimmune diseases, oncological diseases and disorders, infectious diseases, and organ, tissue, or cell transplant tolerance; therapeutic antibodies for the treatment of immune deficiencies, autoimmune diseases, oncological diseases and disorders, infectious diseases, and organ, tissue, or cell transplant tolerance;pharmaceutical drug discovery; research and development in the field of antibody-based therapies; research and development of pharmaceuticals in the fields of oncology, immunology, infectious diseases, and organ, tissue, or cell transplant tolerance; Scientific research, namely, research and analysis services in the fields of artificial intelligence and machine learning analytics; scientific research in the nature of machine learning on single-cell data to identify and quantify cell type differences for the purpose of discovering novel targets; Medical and scientific research for the identification, preparation, and development of antibody libraries; DNA, protein, and antibody screening for scientific research purposes;

GIGAMUNE

Laboratory devices for detecting genetic sequences;Preparations for detecting genetic predispositions for medical purposes;Assays and reagents for use in genetic research; Biochemicals for in vitro and in vivo scientific use; Biochemicals, namely, polypeptides for in vitro research use; Biotechnology formed genes, microbes and enzymes for use in the production of agricultural seeds to enhance plants' growth therefrom; Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields;

GIGAMUNE

Genetic testing for medical purposes; Genetic testing of animals;Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Genetic testing of laboratory animals for research purposes; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Scientific research consulting in the field of immunology; Scientific research in the field of genetics and genetic engineering; Scientific research in the field of immunology;

MAGNIFY

Scientific research, namely, research and analysis services in the fields of artificial intelligence and machine learning analytics; pharmaceutical drug discovery; scientific research in the nature of machine learning on single-cell data to identify and quantify cell type differences for the purpose of discovering novel targets;

SURGE

Medical and scientific research for the identification, preparation, and development of antibody libraries; DNA, protein, and antibody screening for scientific research purposes;